Funds holding IO BIOTECH INC
ISIN US4497781090 · United States
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 11.6K $
- Share of capital
- 0.0 % of 71.9M shares on Nov 10, 2025
A single tracked fund declares this company: these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 33,307 | 11.6K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | -1 | 33,307 | -69.2 % |
| 2026Q1 | 2 | 0 | 108,307 | 0.0 % |
| 2025Q4 | 2 | 0 | 108,307 | 0.0 % |
| 2025Q3 | 2 | 0 | 108,307 | 0.0 % |
| 2025Q2 | 2 | 0 | 108,307 | -47.8 % |
| 2025Q1 | 2 | -1 | 207,307 | -62.1 % |
| 2024Q4 | 3 | 0 | 546,907 | +15.9 % |
| 2024Q3 | 3 | +1 | 471,907 | +216.6 % |
| 2024Q2 | 2 | 0 | 149,040 | -5.6 % |
| 2024Q1 | 2 | 0 | 157,930 | +9.0 % |
| 2023Q4 | 2 | 144,930 |
Institutional managers
12 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Ikarian Capital, LLC | 1,386,565 | 81.4K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 451,852 | 26.5K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 348,352 | 20 $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 301,291 | 18.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 265,792 | 15.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 206,215 | 12.1K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 194,158 | 11.4K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 72,495 | 4.3K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 57,974 | 3.4K $ | as of Mar 31, 2026 |
| Beacon Pointe Advisors, LLC | 42,600 | 2.5K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 33,307 | 2K $ | as of Mar 31, 2026 |
| UBS Group AG | 30,977 | 1.8K $ | as of Mar 31, 2026 |
Declared shareholders of IO BIOTECH INC
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Lundbeckfond Invest A/S | 27.40 % | 21,851,920 | as of Mar 31, 2026 · SCHEDULE 13D |
| HBM Healthcare Investments (Cayman) Ltd. | 3.30 % | 2,433,943 | as of Apr 2, 2026 · SCHEDULE 13G |
| Chernett Jorey | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding IO BIOTECH INC". https://titelia.com/en/stocks/io-biotech-inc-US4497781090